Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. CHYM
3. BRZE
4. USO
5. QCOM
6. DYN
7. PHVS
8. NOVN:SW
9. USB
10. NVS

Go back to Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
(NASDAQ: DFTX) Delayed: 38.23 --0 (-0%)
Previous Close $38.23    52 Week High $ 
Open $38.23    52 Week Low $ 
Day High $38.23    P/E N/A 
Day Low $38.23    EPS $ 
Volume 910